Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 28, 2008; 14(16): 2544-2549
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2544
Published online Apr 28, 2008. doi: 10.3748/wjg.14.2544
Table 4 Colectomy rates at 6 mo and 12 mo compared to clinical response to infliximab
| Response | No surgery | Colectomy | Colectomy |
| at 12 mo | ≤6 mo | ≤12 mo | |
| No response | 0% | 50% | 100% |
| (0/3) | (1/2) | (2/2) | |
| Partial response | 28.60% | 28.60% | 71.40% |
| (2/7) | (2/7) | (5/7) | |
| Complete response | 83.30% | 16.70% | 20% |
| (5/6) | (1/6) | (1/5) | |
| Total | 46.70% | 26.70% | 57.10% |
| (7/15) | (3/16) | (8/14) |
- Citation: Willert RP, Lawrance IC. Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis. World J Gastroenterol 2008; 14(16): 2544-2549
- URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2544.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.2544